We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

17 hedge funds and large institutions have $4.63M invested in Virtus Biotech ETF in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more funds holding

Funds holding: 14 → 17 (+3)

19% more capital invested

Capital invested by funds: $3.89M → $4.63M (+$744K)

2.34% more ownership

Funds ownership: 24.53% → 26.87% (+2.3%)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
17
Holders Change
+3
Holders Change %
+21.43%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
5
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$427K
2
DSC
Duncker Streett & Co
Missouri
+$25.5K
3
UBS Group
UBS Group
Switzerland
+$6.65K
4
BAM
Belpointe Asset Management
Nevada
+$2.2K
5
MCC
Money Concepts Capital
Florida
+$2.06K

Top Sellers

Rank Fund Capital Flow
1
Rockefeller Capital Management
Rockefeller Capital Management
New York
-$160K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$55.3K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$31.1K
4
Citadel Advisors
Citadel Advisors
Florida
-$27.9K
5
Stifel Financial
Stifel Financial
Missouri
-$4.79K
Name Holding Trade Value Shares
Change 		Change in
Stake
Rockefeller Capital Management
1
Rockefeller Capital Management
New York
$1.19M -$160K -3,334 -12%
Royal Bank of Canada
2
Royal Bank of Canada
Ontario, Canada
$803K -$31.1K -650 -4%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$643K -$55.3K -1,155 -8%
Morgan Stanley
4
Morgan Stanley
New York
$565K +$427K +8,927 +353%
Citadel Advisors
5
Citadel Advisors
Florida
$374K -$27.9K -584 -7%
Stifel Financial
6
Stifel Financial
Missouri
$284K -$4.79K -100 -2%
LPL Financial
7
LPL Financial
California
$233K +$718 +15 +0.3%
CCM
8
Coldstream Capital Management
Washington
$211K +$205K +4,285 New
MIFH
9
Migdal Insurance & Financial Holdings
Israel
$136K – – –
Osaic Holdings
10
Osaic Holdings
Arizona
$61K +$1.82K +38 +3%
UBS Group
11
UBS Group
Switzerland
$52.7K +$6.65K +139 +15%
Carson Wealth (CWM LLC)
12
Carson Wealth (CWM LLC)
Nebraska
$27K – – –
DSC
13
Duncker Streett & Co
Missouri
$26.3K +$25.5K +534 New
Northwestern Mutual Wealth Management
14
Northwestern Mutual Wealth Management
Wisconsin
$10.2K – – –
FWM
15
Focused Wealth Management
New York
$9.86K – – –
MCC
16
Money Concepts Capital
Florida
$9.51K +$2.06K +43 +29%
BAM
17
Belpointe Asset Management
Nevada
$2.27K +$2.2K +46 New

BBP Hedge Fund Activity: Q4 2022 in Review

17 of the 6,224 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q4 2022, worth a combined $4.63M — up 19% from $3.89M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new BBP positions and 0 closed out — a net gain of 3 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $427K. The largest seller was Rockefeller Capital Management, cutting an estimated $160K.

  • 17 institutional investors held Virtus Biotech ETF (BBP) as of Q4 2022, up from 14 in Q3 2022.
  • Funds reported $4.63M of Virtus Biotech ETF stock for Q4 2022, up 19% quarter-over-quarter.
  • 3 funds opened new Virtus Biotech ETF positions in Q4 2022 and 0 closed out, a net change of +3 holders.
  • The largest Virtus Biotech ETF buyer in Q4 2022 was Morgan Stanley, an estimated $427K added.
  • The largest Virtus Biotech ETF seller in Q4 2022 was Rockefeller Capital Management, an estimated $160K sold.

Based on aggregated 13F filings for Q4 2022.